Download printed version of program as


One Day on The Liver
 

Scientific Program

Thursday, September 6, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: H. Klinkmann (Rostock, Germany) , B. Walpoth (Geneve, Switzerland)
08:30 THE IMPORTANCE OF THE ENDOTHELIUM IN HEALTH, DISEASE AND REGENERATION
J. Kirkpatrick (Mainz, Germany)
09:00 DEVELOPMENT OF MECHANICAL CIRCULATORY SUPPORT SYSTEMS AND APPLICATION OF THE RELATED TECHNOLOGIES TO ARTIFICIAL ORGANS
Y. Taenaka (Osaka, Japan)
9:30 - 10:00 Coffee Break
10:00 - 12:30 Renal Session - Working Group - Uremic Toxins
Room E.06
Chair: R. Vanholder (Gent, Belgium), Chairman of ESAO Working Group Uremic Toxins
10:00 THE HISTORY AND ROLE OF EUTox IN UREMIC TOXICITY 
R. Vanholder (Gent, Belgium)
10:25 UREMIC TOXICITY: GENERAL OVERVIEW 
G. Cohen (Vienna, Austria)
10:50 SCIENTIFIC APPROACHES APPLIED BY EUTox 
J. Jankowki (Berlin, Germany)
11:15 UREMIC TOXINS AND ENDOTHELIUM 
P. Brunet (Marseille, France)
11:40 UREMIC TOXINS AND LEUKOCYTES 
G. Glorieux (Gent, Belgium)
12:05 THERAPEUTIC APPROACHES TO COPE WITH UREMIC TOXICITY
U. Baurmeister (Berlin, Germany)
12:45 - 13:45 ESAO Corporate Symposium: Milestones on the way from artificial organs to regenerative medicine Audi Max
Chair: I. Ledebo (Lund, Sweden), B. Walpoth (Geneve, Switzerland)
14:00 - 15:30 Renal Session - Hemodialysis and Modelling
Room E.06
Chair: S. Di Giulio (Rome, Italy), A. Buscaroli (Bologna, Italy)
14:00 HOW TO AUTOMATICALLY IMPROVE DIALYTIC OUTCOMES? A COMPARTMENTAL MODEL APPROACH 21
G. Casagrande, R. Fumero, M.L. Costantino (Milan, Italy)
14:15 NOCTURNAL HEMODIALYSIS WITH THE GENIUS® DIALYSIS SYSTEM 26
R. De Smet, A.M. Dhondt, S. Eloot, S. Claus, R. Vanholder (Gent, Belgium)
14:30 TREATMENT OUTCOME OF HEPATITIS C IN HEMODIALYSIS PATIENTS 51
A. Sikole, P. Dzekova, N. Selja, M. Gaseva , M. Zabzun, S. Muharemi, A. Asani, V. Amitov, G. Selim, S. Gelev, S. Mena, V. Grunevska, M. Polenakovic (Skopje, Macedonia)
14:45 Kt/V IS GONE, AND INTEGRATIVE MEDICINE HAS COME IN A FIELD OF DIALYSIS THERAPY 155
T. Agishi, M. Akamatsu, Y. Okuno (Tokyo, Japan)
15:00 EVALUATION OF HEMODIALYSIS (HD) ADEQUACY USING ONLINE KT/V AND SINGLE-POOL VARIABLE-VOLUME (SPVV) UREA KT/V  193
A.E. Grzegorzewska, W. Banachowicz (Poznań, Poland)
15:15 HEMODIALYSIS MEMBRANES AND OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS 204
P. Dejanov, V. Gerasimovska, A. Oncevski, A. Sikole, B. Dejanova (Skopje, Macedonia)
15:30-17:00 Coffee Break & Poster Session
17:00 - 18:00 Renal Session - Continuous venovenous hemodiafltration Room E.06
Chair: M. Polenakovic (Skopje, Macedonia) , K. Metodiev (Varna, Bulgaria)
17:00 THE FIRST EXPERIENCE OF APPLICATION SLOW CONTINUOUS THERAPY METHODS  ON “MULTIFILTRATE“ DEVICE IN THE REPUBLIC OF BELARUS 2
I. Rovdo, V. Kirkovsky, A. Korolik (Minsk, Belarus)
17:15 EASY AND EFFECTIVE WAY TO PREVENT HYPOTHERMIA IN ACUTE RENAL FAILURE (ARF) PATIENTS ON CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF) 22
J.W. Chang, E.Y. Im, S.J. Lee, H.S. Park, S.K. Park, S.B. Kim (Seoul, South Korea)
17:30 EXTENDED DAILY HEMODIAFILTRATION (EDHDF) IN THE THERAPY OF ACUTE RENAL FAILURE 44
E. Mesic, M. Atic  (Tuzla, Bosnia and Herzegovina)
17:45 CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) AND PLASMA EXCHANGE (PE) IN  CRITICALLY ILL NEWBORNS AND INFANTS 48
R. Ponikvar, A. Kandus, J. Kovač, V. Premru, B. Knap, A. Marn, Š. Grosek, A. Gostiša-Kornhauser, J. Primožič, J. Buturović (Ljubljana, Slovenia)
Thursday, September 6, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: H. Klinkmann (Rostock, Germany) , B. Walpoth (Geneve, Switzerland)
08:30 THE IMPORTANCE OF THE ENDOTHELIUM IN HEALTH, DISEASE AND REGENERATION
J. Kirkpatrick (Mainz, Germany)
09:00 DEVELOPMENT OF MECHANICAL CIRCULATORY SUPPORT SYSTEMS AND APPLICATION OF THE RELATED TECHNOLOGIES TO ARTIFICIAL ORGANS
Y. Taenaka (Osaka, Japan)
9:30 - 10:00 Coffee Break
10:00 - 11:30 Heart Session - Fluid Dynamics
Audi Max
Chair: P. Verdonck (Ghent, Belgium), K. Affeld (Berlin, Germany)
10:00 GAS EXCHANGE IN VIRTUAL RESPIRATORY SYSTEM – SIMULATION OF VENTILATION WITHOUT LUNGS MOVEMENT 73
T. Golczewski (Warsaw, Poland)
10:15 A MULTISCALE MODELING OF THROMBOSIS USING COUPLING OF DISSIPATIVE PARTICLE DYNAMICS WITH CONTINUUM FINITE ELEMENT METHOD  136
N. Filipovic, M. Kojic, A. Tsuda (Kragujevac, Serbia)
10:30 NUMERICAL MODELING AND VISUALIZATION OF BLOOD DAMAGE IN THREE STANDARD MECHANICAL VALVES 137
L. Goubergrits, U. Kertzscher, K. Affeld (Berlin, Germany)
10:45 HEPATIC ARTERY/PORTAL VEIN FLOW COMPETITION DURING HYPOTHERMIC MACHINE PERFUSION OF THE LIVER 139
W. Hillewaert, Q. Liu, K. Vekemans, P. Segers, P. Verdonck, J. Pirenne, J. Brasil, D. Monbaliu (Leuven, Belgium)
11:00 EXPERIMENTAL STUDY OF PATIENT SPECIFIC KINK IN ARTERIO-VENOUS GRAFT USING PARTICLE IMAGE VELOCIMETRY 192
K. Van Canneyt, R. Kaminsky, L. Antiga, J. Tordoir, P. Verdonck, S. Eloot (Gent, Belgium)
11:15 DEVELOPMENT OF A SHEAR STRESS MEASUREMENT TECHNIQUE FOR VENTRICULAR ASSIST DEVICES 200
A. Berthe, U. Kertzscher, L. Goubergrits, C. Christensen, K. Affeld (Berlin, Germany)
11:30 - 12:30 Tissue Engineering-Symposium
Chair: S. Nehrer (Krems, Austria)
11:30 CLINICAL EXPERIENCE WITH THE CARTILAGE REGENERATION SYSTEM (CaReS)
S. Nehrer (Krems, Austria)
11:50 CULTIVATION OF CELLS IN A 3D COLLAGEN MATRIX
K. Lämmle (Stuttgart, Germany)
12:10 THE SPECIAL MEANING OF RISK MANAGEMENT REGARDING TISSUE ENGINEERING PRODUCTION PROCEDURES
M. Pichler (Krems, Austria)
12:45 - 13:45 ESAO Corporate Symposium - Milestones on the way from artificial organs to regenerative medicine
Chair: I. Ledebo (Lund, Sweden), B. Walpoth (Geneve, Switzerland)
12:45 Major contributions from the industry to the development of dialysis therapy: The three most important innovations from Fresenius      
J Vienken, Fresenius Medical Care, Bad Homburg, Germany      
13:00 Major contributions from the industry to the development of dialysis therapy: The three most important innovations from Gambro      
I Ledebo, Gambro, Lund, Sweden        
13:15 Convective forces for improved dialytic therapy      
C Tetta, Fresenius Medical Care, Bad Homburg, Germany      
13:30 From synthetic to biological separation devices      
B Krause, Gambro, Hechingen, Germany      
Thursday, September 6, 2007 14:00 - 15:30 Heart Session - Assist Device - Experimental Audi Max
Chair: U. Steinseifer (Aachen, Germany), J.F. del Canizo (Madrid, Spain)
14:00 LINEAR BLOODPUMP - FIRST RESULTS IN MOCK CIRCULATION 111
M. Grossmann, W. Juettner, J. Landrath, I. Merkel, J.D. Schmitto, F.A. Schoendube (Goettingen, Germany)
14:15 ANTITHROMBOGENICITY OF UNDULATION PUMP VENTRICULAR ASSIST DEVICES IMPLANTED INTO GOATS FOR MORE THAN 3 MONTHS WITHOUT ANTICOAGULANT 113
K. Imachi, A. Baba, Y. Shiraishi, T. Yambe, H. Liu, K. Sekine, I. Saito, T. Isoyama, A. Kouno, T. Ono, P. Dobsak, Y. Abe (Sendai, Japan)
14:30 IMPROVEMENT OF RECOVERY-DIRECTED LEFT VENTRICULAR ASSIST DEVICE (RDLVAD) SO AS TO EFFECTIVELY SUPPORT THE ENTIRE PROCESS OF RECOVERY FROM HEART FAILURE  117
K. Watanabe, F. Miyawaki, K. Yoshimoto (Saitama, Japan)
14:45 PEDIATRIC HEART SUPPORT WITH A NEWLY DEVELOPED, CATHETER BASED PULSATILE 12F ROTARY BLOOD PUMP; AN ANIMAL STUDY 122
F. Rega, I. Vantichelen, H. Bollen, F. Kirchhof, G. Derjung, R. Damen, Schwandtner, R. Lutz, B. Meyns (Leuven, Belgium)
15:00 IN VIVO EVALUATION OF THE EFFECTS OF PULSATILE VAD OPERATING MODE ON LV HEMODYNAMICS 124
P. Ferrazzi, M.Glauber, N. Borenstein, L. Behr, S. Rinaldi (Bergamo, Italy)
15:15 HISTOLOGICAL CHANGES IN A SHEEP MODEL OF CHRONIC HEART FAILURE INDUCED BY MULTIPLE SEQUENTIAL CORONARY MICROEMBOLIZATION 126
J.D. Schmitto, P. Ortmann, E. Hintze, C. Gielok, S.N. Gupta, A. Popov, R. Wachter, M. Grossmann, F.A. Schoendube (Goettingen, Germany)
15:30 - 17:00 Coffee Break & Poster Session
17:00 - 18:00 Heart Session - Modelling and Simulation Audi Max
Chair: H. Schima (Vienna, Austria), M. Darowski (Warsaw, Poland)
17:00 NEW ALGORITHMS FOR IMPROVEMENT OF THE ANALYSIS OF DATA FROM HEART VALVE PROSTHESES QUALIFICATION TESTS, BASED ON 1&2-DIMENSIONAL SIGNALS 142
K. Rohr, P. Kostka, Z. Nawrat (Zabrze, Poland)
17:15 BLOOD GLUCOSE PREDICTION IN TYPE I DIABETICS THROUGH AUTOREGRESSIVE MODEL 158
V. Canonico, D. Fruttini, E. Sarti, P.G. Fabietti (Perugia,  Italy)
17:30 MODELING OF GLUCOSE-INSULIN REGULATION DURING PERITONEAL DIALYSIS 160
M. Galach, A. Weryński, B. Lindholm (Warsaw Poland)
17:45 THE EFFECT OF THE ARTERIAL LUMPED PARAMETER MODEL STRUCTURE ON SELECTED VENTRICULAR AND CIRCULATORY PARAMETERS IN A PHYSICAL, NUMERICAL OR HYBRID MODEL 168
M. Kozarski, G. Ferrari, K. Zielinski, K.Gorczynska, K.J. Palko, A. Tokarz, M. Darowski (Warsaw, Poland)
 
Thursday, September 6, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: H. Klinkmann (Rostock, Germany) , B. Walpoth (Geneve, Switzerland)
08:30 THE IMPORTANCE OF THE ENDOTHELIUM IN HEALTH, DISEASE AND REGENERATION
J. Kirkpatrick (Mainz, Germany)
09:00 DEVELOPMENT OF MECHANICAL CIRCULATORY SUPPORT SYSTEMS AND APPLICATION OF THE RELATED TECHNOLOGIES TO ARTIFICIAL ORGANS
Y. Taenaka (Osaka, Japan)
9:30 - 10:00 Coffee Break
10:00 - 11:30 One Day on the Liver I Room E.11
Chair: C. Legallais (Compiegne, France), J. Vienken (Bad Homburg, Germany)
What is new in Japan and the US?
10:00 REPORT FROM THE USA
S. Ash (Lafayette, USA)
10:15 REPORT FROM JAPAN
H. Hirasawa (Chiba, Japan)
Aspects concerning the (patho)physiology of the failing liver
10:30 TOXINS IN LIVER FAILURE - WHAT IS RELEVANT, WHAT DO WE HAVE TO REMOVE?
M. Joannidis (Innsbruck, Austria)
10:50 COAGULATION, ANTICOAGULATION AND THE FAILING LIVER
D. Falkenhagen (Krems, Austria)
11:10 ALCOHOLIC LIVER CIRRHOSIS: SUCCESSFUL TREATMENT WITH NOVEL AUTOLOGOUS LIVER CELL TRANSPLANTATION PROCEDURE
T. Lindl (München, Germany)
11:30 - 12:30 Therapeutic progress in acute renal failure with new membranes - Symposium sponsored by Gambro 
Chair: R. Oberbauer (Linz, Austria)
11:30 FUNCTION AND FEATURES OF A NEW MEMBRANE TYPE
M. Storr (Hechingen, Germany)
11:50 REMOVAL OF FREE LIGHT CHAINS IN MYELOMA-INDUCED RENAL FAILURE
C. Hutchison (Birmingham, United Kingdom)
12:10 ANTI-INFLAMMATORY EXTRACORPOREAL THERAPIES IN CRITICALLY ILL PATIENTS
M. Joannidis (Innsbruck, Austria)
12:45 - 13:45 ESAO Corporate Symposium - Milestones on the way from artificial organs to regenerative medicine
Audi Max
Chair: I. Ledebo (Lund, Sweden), B. Walpoth (Geneva, Switzerland)
12:45 Major contributions from the industry to the development of dialysis therapy: The three most important innovations from Fresenius  
J Vienken, Fresenius Medical Care, Bad Homburg, Germany  
13:00 Major contributions from the industry to the development of dialysis therapy: The three most important innovations from Gambro  
I Ledebo, Gambro, Lund, Sweden    
13:15 Convective forces for improved dialytic therapy  
C Tetta, Fresenius Medical Care, Bad Homburg, Germany  
13:30 From synthetic to biological separation devices  
B Krause, Gambro, Hechingen, Germany  
Thursday, Septmber 6 2007 14:00 - 15:30 One Day on the Liver II Room E.11
Chair: I. Sauer (Berlin, Germany), D. Falkenhagen (Krems, Austria)
Clinical application of liver support systems - where do we stand today?
14:00 PROMETHEUS: IMPACT ON PRURITUS
K. Rifai (Hannover, Germany)
14:15 MARS VERSUS PROMETHEUS IN CLINICAL PRACTICE: WHAT DO WE KNOW?
A. Wilmer (Leuven, Belgium)
14:30 SELECTIVE PLASMA FILTRATION THERAPY (SEPET) FOR LIVER FAILURE - EARLY CLINICAL EXPERIENCE
J. Rozga (Los Angeles, USA)
14:45 PLASMAPERESIS IN CASES OF LIVER FAILURE - A SIMPLE BUT EFFECTIVE CONCEPT
K. Inoue (Yokohama, Japan)
15:00 BIOARTIFICIAL LIVER SUPPORT FOR ACUTE DECOMPENSATION OF CHRONIC LIVER DISEASE: CLINICAL RESULTS
M. Millis (Chicago, USA)
15:30 - 17:00 Coffee Break & Poster Session
17:00 - 18:00  One Day on the Liver III Room E.11
Chair: I. Sauer (Berlin, Germany), V. Weber (Krems, Austria)
Concepts and Technologies
17:00 CELLS FOR BIOARTIFICIAL LIVER SUPPORT
R. Hoekstra (Amsterdam, The Netherlands)
17:15 DEVELOPMENT AND EVALUATION OF A NEW WHOLE-BLOOD PERFUSED BIOREACTOR
N. Kobayashi (Okayama, Japan)
17:30 HEPA WASH
B. Kreymann (Munich, Germany)
17:45 CARBON BLOCK VS. GRANULAR COLUMNS FOR BINDING OF LIVER FAILURE TOXINS
S. Ash (Lafayette, USA)
Friday, September 7, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: G. Rakhorst (Groningen, The Netherlands), S. Stefoni (Bologna, Italy)    
08:30 TOWARDS BIODEGRADABLE VASCULAR GRAFTS
B. Walpoth (Geneva, Switzerland)
09:00 REGENERATIVE MEDICINE IN THE AGE OF BIOTECHNOLOGY
M. Lysaght (Providence, USA)
09.30 - 10.00 Coffee Break
10:00 - 11:30 Liver Session I Room E.06
Chair: U. Baurmeister (Berlin, Germany) , S. Ash (Lafayette, USA)
10:00 DEVELOPMENT OF A BIOARTIFICIAL LIVER DEVICE WITH CULTURE OF HUMAN LIVER-DERIVED CELLS
V. Fonsato, M.B. Herrera, M. Caronna, S. Buttiglieri, G. Camussi, C. Tetta (Turin, Italy) 59
10:15 BIOARTIFICIAL LIVER BASED ON HOLLOW FIBER MEMBRANE: PHYSICAL AND BIOLOGICAL CHARACTERIZATION AT MICRO SCALE LEVEL
A. Gautier, H.-D. Lemke, M. Dufresne, C. Legallais (Compiègne, France) 60
10:30 THREE DIMENSIONAL GROWTH OF HEPATIC CELLS IN ALGINATE BEADS. STUDIES OF BEADS OPTIMIZATION FOR FLUIDISED BED BIOREACTOR
A. Kinasiewicz, A. Gautier, D. Lewinska, M. Dufresne, A. Smietanka, J. Bukowski, C. Legallais, A. Weryński (Warsaw, Poland) 62
10:45 FRACTIONATED PLASMA SEPARATION AND ADSORPTION IN ACUTE-ON-CHRONIC LIVER FAILURE PATIENTS RESULTS IN LOSS OF PRO- AND ANTICOAGULANT FACTORS
P. Evenepoel, B. Meijers, P. Verhamme, A. Wilmer, F. Nevens, K. Claes, D. Kuypers, Y. Vanrenterghem (Leuven, Belgium) 65
11:00 PROMETHEUS IN THE TREATMENT OF EXPERIMENTAL ACUTE LIVER FAILURE DECREASES INTRACRANIAL PRESSURE SIGNIFICANTLY
M. Ryska, T. Pantoflicek, E. Laszikova, O. Ryska, J. Prazak, E. Koblihova (Prague, Czech Republic) 70
11:15 ELAD® CELLULAR AND SYSTEM PERFORMANCE IMPROVEMENTS
J. Brotherton, D. He, S. Asslani, M. Millis (San Diego, USA) 205
11:30 - 12:40 Symposium Sponsored by Fresenius Medical Care
Chair: J. Vienken  (Bad Homburg, Germany)
How to improve the efficiency of blood purification therapy?  
11:30 RENAL PROGENITOR/STEM CELL THERAPY FOR THE TREATMENT OF ACUTE AND CHRONIC RENAL FAILURE  
D. Humes (Michigan, USA)  
12:00 ON LINE HDF IN THE CLINICAL SETTING  
R. Greenwood (Stevenage, United Kingdom)  
12:20 ON-LINE HEMODIAFILTRATION: THE MOST EFFECTIVE DIALYSIS MODALITY. CLINICAL EXPERIENCE AND RESULTS FROM THE HUNGARIAN FRESENIUS MEDICAL CARE NETWORK 53  
L. Vaslaki (Sopron, Hungary)  
12:45 - 13:45 Presidential Lunch Symposium Audi Max
Round table discussion:
FUTURE OF ARTIFICIAL ORGAN RESEARCH AND DEVELOPMENT
  Moderation: Y. Nosé (Houston, USA), E. Wolner (Vienna, Austria)
Participants: 
M. Lysaght (Providence, USA)
J. Long (Salt Lake City, USA)
B. Walpoth (Geneva, Switzerland)
G. Rakhorst (Groeningen, The Netherlands)
Y. Taenaka (Osaka, Japan)
Friday, September 7 2007 14:00 - 15:30 Liver Session II Room E.06
Chair: R. Hoekstra (Amsterdam, The Netherlands), J. Hartmann (Krems, Austria)
14:00 FRACTIONATED PLASMA SEPARATION AND ADSORPTION INDUCES FISTULA THROMBOSIS IN MAINTENANCE HEMODIALYSIS PATIENTS 66
B. Meijers, P. Evenepoel, P. Verhamme, K. Claes, D. Kuypers, B. Bammens, Y. Vanrenterghem (Leuven, Belgium)
14:15 THE SLIDEOBSERVER – A NEW CONCEPT FOR THE PARALLEL OPERATION OF TWO SLIDEREACTOR BIOREACTOR SYSTEMS 69
N. Raschzok, M.H. Morgul, F.W.R. Vondran, R. Schwartlander, I.M. Sauer (Berlin, Germany)
14:30 TRANSPLANTATION OF PRIMARY HUMAN HEPATOCYTES – IRON OXIDE LABELLING FOR CELL DETECTION VIA MRI 132
M.H. Morgul, N. Raschzok, R. Schwartlander, F.W.R. Vondran, G. Pless, J. Pinkernelle, U. Teichgraber, I.M. Sauer (Berlin, Germany)
14:45 ISOLATION, CHARACTERIZATION AND DIFFERENTIATION OF  HUMAN HEPATIC  STEM CELLS 146
M. B. Herrera, S. Bruno, C. Tetta, S. Buttiglieri, V. Fonsato, B. Bussolati, S. Gatti, G. Camussi (Torino, Italy)
15:00 ASSESSING ISCHEMIC AND NON-ISCHEMIC LIVER VIABILITY BY APPARENT DIFFUSION COEFFICIENT. A PILOT STUDY 150
Q. Liu, D. Monbaliu, K. Vekemans, R. Peeters, F. De Keyzer, T. Dresselaers, Y. Ni, P. van Heck, J. Brassil, G. Marchal, J. Pirenne (Leuven, Belgium)
15:15 BILIRUBIN ADSORPTION USING TITANUM OXIDE PARTICLES 214
T. Asano, K. Tsuru, S. Hayakawa, A. Osaka (Okayama, Japan)
15:30 - 17:00 Coffee Break & Poster Session
17:00 - 18:00 Renal Session - Peritoneal Dialysis Room E.06
Chair: A. Sikole (Skopje, Macedonia), H. Holzer (Graz, Austria)
17:00 ROLE OF CYSTATIN C (CYS) IN PERITONEAL EQUILIBRATION TEST 25
F.M. D'Ascenzo, D. Galli, N. Miani, F. Frangiolini, S. Condò, T. Tullio, M. Ferrannini, G.M. Taccone (Rome, Italy)
17:15 PERITONEAL DIALYTIC TREATMENT (PD) IN CARDIOPATHIC PATIENTS  49
G.E. Russo, A. Centi, A. Morgia, B. Coppola, M.Cavallini (Rome, Italy)
17:30 THE IMPACT OF ICODEXTRIN ON QUALITY OF LIFE IN DIABETIC PATIENTS ON PERITONEAL DIALYSIS: RESULTS OF A RANDOMIZED CONTROLLED CLINICAL TRIAL 54
M.J. Ventura, A. Cisneros, C. Furlong, M. Vicente, D. Villanueva, R. Paniagua, D.R. Walker, J. DuChane, I. Prieto, J. Divino, J.C. Blackburn, S.K. Bhattacharyya (Mexico City, Mexico)
17:45 DIFFERENCES IN CLINICAL EVALUATION OF DIALYZED PATIENTS WITH OR WITHOUT HEART FAILURE 206
A.E. Grzegorzewska, M. Młot-Michalska (Poznań, Poland)
Friday, September 7, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: G. Rakhorst (Groningen, The Netherlands), S. Stefoni (Bologna, Italy)
08:30 TOWARDS BIODEGRADABLE VASCULAR GRAFTS
B. Walpoth (Geneva, Switzerland)
09:00 REGENERATIVE MEDICINE IN THE AGE OF BIOTECHNOLOGY
M. Lysaght (Providence, USA)
09.30 - 10.00 Coffee Break
10:00 - 11:30 Heart Session - Assist Device - Clinical Audi Max
Chair: G. Wieselthaler (Vienna, Austria) , P. Portner (Stanford, USA)
10:00 Mechanical Circulatory Support Today: Choices and Challenges (invited lecture)
P. Portner  (Stanford, USA)
10:30 VENTRICULAR ASSIST DEVICES: FOURTEEN YEARS EXPERIENCE OF A SINGLE CENTER  107
L. Barozzi, A. Forni, F. Innocente, G.B. Luciani, G. Faggian, A. Mazzucco (Verona, Italy)
10:45 VENTRICULAR ASSISTANCE WITH BERLIN HEARTTM VENTRICULAR ASSIST DEVICE: ANALYSIS OF 31 IMPLANTATIONS 110
M. Cikirikcioglu, E. Pektok, J. Sierra, A. Panos, N. Murith, E. Khabiri, A. Kalangos (Geneva, Switzerland)
11:00 EXPERIMENTAL BIOMECHANICAL HEARTS SUPPORT A FAILING MYOCARDIUM WITH A CLINICALLY RELEVANT PUMPING CAPACITY 112
N.W. Guldner, P. Klapproth, M. Geier, Ch. Enzensberger, M. Großherr, M. Mahmoodi, R. Noel, H.-H. Sievers ( Luebeck, Germany)
11:15 LEFT VENTRICULAR CIRCULATORY SUPPORT AS BRIDGE TO HEART TRANSPLANTATION IN CHAGAS' DISEASE CARDIOMYOPATHY 115
L.F.P. Moreira, J. Galantier, A. Benício, I.A. Cestari, N.A.G. Stolf, A.A. Leirner (São Paulo, Brazil)
11:30 - 12:30 Current Problems in Cardiac Assist
Chairmen: G. Wieselthaler (Vienna), B. Meyns (Leuven)
11:30 First Clinical Use of a Minimal Invasive Cardiac Assist System (Circulite)     
B. Meyns (Leuven)    
11:50 Anticoagulation or Antiaggregation: What do we need to prevent VAD Thrombosis    
G. Wieselthaler (Vienna)    
12:10 Experiences with chronic application of the Incor-VAD    
 J. Mueller (Berlin)    
   
12:45 - 13:45 Presidential Lunch Symposium
Round table discussion:
FUTURE OF ARTIFICIAL ORGAN RESEARCH AND DEVELOPMENT
Moderation: Y. Nosé (Houston, USA), E. Wolner (Vienna, Austria)
Participants: 
M. Lysaght (Providence, USA)
J. Long (Salt Lake City, USA)
B. Walpoth (Geneva, Switzerland)
G. Rakhorst (Groeningen, The Netherlands)
Y. Taenaka (Osaka, Japan)
Friday, September 7, 2007 14:00 - 15:30 Heart Session - General Audi Max
Chair: B. Meyns (Leuven, Belgium), K. Imachi (Sendai, Japan)
14:00 TIME RESOLVED PIV AORTIC FLOW FIELD STUDY OF DIFFERENTLY DESIGNED CONTEMPORARY BI-LEAFLET PROSTHESES 7
T. Akutsu, J. Saito, T. Suzuki, X. D. CAO, I. Hayashi (Yokohama, Japan)
14:15 RESEARCH OF THE BIOTECHNICAL DEVICE FOR REVASCULARIZATION OF ISCHEMIZED MYOCARDIUM PARTS WITH THE AID OF CAD/CAM/CAE-TECHNOLOGY 12
V.V. Morozov, V.P. Ganin, A.V. Zhdanov (Vladimir, Russia)
14:30 PRACTICAL IN-VITRO BLOOD COMPATIBILITY TESTING OF PULSATILE PUMP  14
T. Nakayasu, K. Iwasaki, M. Eguchi, N. Kubo, K. Ishihara, M. Umezu (Tokyo, Japan)
14:45 DEVELOPMENT OF AN AUTO CALIBRATION METHOD FOR THE IMPLANTABLE BLOOD PRESSURE SENSOR IN THE UPVAD 15
I. Saito, W. Shi, T. Chinzei, T. Isoyama, H. Miura, A. Kouno, T. Ono, H. Nakagawa, S. Yamaguchi, N. Mitsumune, Y. Inoue, A. Kishi, Y. Abe (Tokyo, Japan)
15:00 MITRAL ANNULOPLASTY WITH THE BIODEGRADABLE RING IN THE ADULTS: SHORT TERM RESULTS  16
B.H. Walpoth, S. Karaca, M. Cikirikcioglu, A. Kalangos (Geneva, Switzerland)
15:15 NEW DIAGNOSIS MACHINE FOR THE QUANTITATIVE EVALUATION OF THE BAROREFLEX SENSITIVITY IN ARTIFICIAL HEART CIRCULATION 17
T. Yambe, Y. Luo, M. Yoshizawa, S. Nitta, K. Imachi, M. Honda (Sendai, Japan)
15:30 - 17:00 Coffee Break & Poster Session
17:00 - 18:00 Tissue Engineering I Audi Max
Chair: A. Bader (Leipzig, Germany), J. Wojcicki (Warsaw, Poland)
17:00 A SYSTEMATIC PARAMETRIC ANALYSIS TO IMPROVE CRYOPRESERVATION OF CELLS IN SUSPENSION 171
I. Bernemann, N. Hofmann, A. Szentivanyi, B. Glasmacher (Hannover, Germany)
17:15 MICRO MACHINED HYBRID ACTUATOR WITH CULTURED MUSCLE CELL FOR ARTIFICIAL ORGANS 175
S. Hashimoto, H. Tsutsui, S. Mochizuki, M. Yoshiura, K. Akazawa, M. Ohsuga, S. Uto, H. Kobayashi, K. Yamasaki, H. Kondo, T. Fujisato, H. Otani, K. Yoshinaka (Osaka, Japan)
17:30 POROUS POLY (L- LACTIDE ACID)/HYDROXYAPATITE RODS NANOCOMPOSITE SCAFFOLD FOR BONE TISSUE ENGINEERING 183
E. Nejati, H. Mirzadeh, M. Zandi (Tehran, Iran)
17:45 PRODUCTION OF ORIENTED SMOOTH MUSCLE CELL LAYERS FOR OESOPHAGEAL TISSUE ENGINEERING 184
A.C. Ritchie, K.S. Chian, S. Wijaya, W.F. Ong, S. Zhong (Nanyang, Singapore)
Friday, September 7, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: G. Rakhorst (Groningen, The Netherlands), S. Stefoni (Bologna, Italy)
08:30 TOWARDS BIODEGRADABLE VASCULAR GRAFTS
B. Walpoth (Geneva, Switzerland)
09:00 REGENERATIVE MEDICINE IN THE AGE OF BIOTECHNOLOGY
M. Lysaght (Providence, USA)
09.30 - 10.00 Coffee Break
10:00 -11:30 Apheresis Room E.11
Chair: K. Derfler (Vienna, Austria), J. Emmrich (Rostock, Germany)
10:00 WORLD APHERESIS REGISTRY 2005 DATA (invited lecture) 3
B. Stegmayr, J. Ptak, B. Wikström, G. Berlin, C.G. Axelsson, A. Griskevicius, P. Centoni, G. Liumbruno, P. Molfettini, J. Audzijoniene, K. Mokvist, B. Nilsson Sojka, W. Ramlow, M. Blaha, V. Witt V (Umea, Sweden)
10:30 SUDDEN HEARING LOSS AND HELP APHERESIS - A SINGLE CENTER EXPERIENCE 1
H. Prophet, W. Ramlow (Rostock, Germany)
10:45 RHEOPHERESIS: SAFETY AND EFFICACY OF A SEMISELECTIVE PLASMATHERAPY 4
G. Vischini, M. Ferrannini, E. Staffolani, N. Miani, A. Naticchia, F.M. D’Ascenzo, G. Splendiani, N. Di Daniele (Rome, Italy)
11:00 REDUCTION OF MYELOID/PLASMACYTOID DENDRITIC CELLS AND G/D T CELLS IN AN EX VIVO MINIMODULE CIRCULATION MODEL 6
G. Waitz, P. Ahrenholz, S. Liebe, J. Emmrich, W. Ramlow (Rostock, Germany)
11:15 PROGNOSTIC FACTORS AND EFFICACY OF CONVENTIONAL PLASMA EXCHANGE IN TREATMENT OF MYASTHENIC CRISIS   213
M.A.F. Zanaty, Y.A. Al-Hendy, T.A. Ghonemy,  A. Abdelhafez (Zagazig, Egypt)
11:30 - 12:30 Apheresis - sponsored Symposium 
Chair: B. Stegmayr (Umea, Sweden), K. Derfler (Vienna, Austria)
CURRENT STATUS OF ADSORPTIVE CYTAPHERESIS IN INFLAMMATORY BOWEL DISEASES
J. Emmrich (Rostock, Germany)
CURRENT STATUS OF APHERESIS THERAPY IN KIDNEY TRANSPLANTATION
K. Derfler (Vienna, Austria)
12:45 - 13:45 Presidential Lunch Symposium Audi Max
Round table discussion:
FUTURE OF ARTIFICIAL ORGAN RESEARCH AND DEVELOPMENT
  Moderation: Y. Nosé (Houston, USA), E. Wolner (Vienna, Austria)
Participants: 
M. Lysaght (Providence, USA)
J. Long (Salt Lake City, USA)
B. Walpoth (Geneva, Switzerland)
G. Rakhorst (Groeningen, The Netherlands)
Y. Taenaka (Osaka, Japan)
Friday, September 7 2007 14:00 - 15:30 Biomaterials I Room E.11
Chair: J. Wojcicki (Warsaw, Poland), T. Groth (Halle, Germany)
14:00 DEVELOPMENT OF FLEXIBLE BIOCOMPATIBLE PHOTOPOLYMERS AS ARTIFICIAL VASCULAR REPLACEMENT MATERIALS 84
S. Baudis, M. Schuster, C. Turecek, H. Bergmeister, G. Weigel, J. Stampfl, F. Varga, R. Liska (Vienna, Austria)
14:15 ELECTROSPINNING POLYURETHANE FOR SMALL DIAMETER VASCULAR GRAFTS 86
C. Grasl, M. Stoiber, A. Nigisch, H. Schmallegger, H. Bergmeister, G. Weigel, H. Schima (Vienna, Austria)
14:30 COLLAGEN IMMOBILIZATION ONTO HEMA GRAFTED PDMS USING PLASMA TO ENHANCE EPITHEIAL CELL ATTACHMENT FOR CORNEAL APPLICATIONS: IN VITRO AND IN VIVO ASSAYS 92
A. Karkhaneh, H. Mirzadeh, A.R. Ghaffariyeh (Tehran, Iran)
14:45 ELECTROSPINNING OF DRUG LOADED POLY(e-CAPROLACTONE) NANOFIBERS: TOWARDS NOVEL DEGRADABLE SMALL-SIZED VASCULAR GRAFTS 96
B. Nottelet, D. Mandracchia, R. Gurny, M. Möller, E. Pektok, B.H. Walpoth (Geneva, Switzerland)
15:00 IN-VITRO CYTOTOXICITY ASSAYS OF DLC FILM COATING FOR ARTIFICIAL HEART BLOOD PUMP 98
Y. Ohgoe, K. Kanasugi, K. K. Hirakuri, A. Funakubo, Y. Fukui (Saitama, Japan)
15:15 IMMOBILIZATION OF GLYCOSAMINOGLYCANS ONTO POLY (L-LACTIDE) FILMS FOR TISSUE ENGINEERING APPLICATIONS 105
Z.-M. Liu, T. Groth (Halle, Germany)
15:30 - 17:00 Coffee Break & Poster Session
17:00 - 18:00 Biomaterials II Room E.11
Chair: J. Stampfl (Vienna, Austria), U. Kertzscher (Berlin, Germany)
17:00 EXPERIMENTAL AORTIC REPLACEMENT IN A RAT MODEL WITH DEGRADABLE SYNTHETIC VASCULAR PROSTHESIS: ANGIOGRAPHIC RESULTS 93
D. Mugnai, M. Cikirikcioglu, J.C. Tille, E. Pektok, A. Kalangos, G. Bowlin, B.H. Walpoth (Geneva, Switzerland)
17:15 EFFECTS OF WETTING OF SMALL-DIAMETER ePTFE GRAFTS BY ALCOHOL ON ENDOTHELIALISATION IN A RAT MODEL 100
E. Pektok, M. Cikirikcioglu, J.C. Tille, A. Kalangos, B.H. Walpoth (Geneva, Switzerland)
17:30 CROSSLINKED COLLAGEN-PEO NANOFIBERS AS CELL CULTURE SUBSTRATE  103
A. Szentivanyi, U. Assmann, R. Schuster, B. Glasmacher (Hannover, Germany)
17:45 NATURAL CARRIER FOR NANOPARTICLES - TARGETED DELIVERY OF DRUGS 194
H. Bäumler, M. Brähler, R. Georgieva, A. Höning, A. Müller, M. Müller, J. Pinkernelle, V. Staedtke, U. Teichgräber (Berlin, Germany)
Saturday, September 8, 2007 8:30 - 9:30 Plenary Session Audi Max
Chair: U. Losert (Vienna, Austria), E. Wieselthaler (Vienna, Austria)
08:30 HYPOTHERMIA DURING AND AFTER CARDIAC ARREST: THE VIENNA BRAIN RESUSCITATION RESEARCH GROUP
W. Behringer, F. Sterz, M. Holzer, W. Weihs, A. Schratter, D. Krizanac, A. Janata, K. Bayegan, M. Frossard, W. Sipos, U. Losert, A.N. Laggner (Vienna, Austria)
09:00 MICRO-MECHANICS OF EMBRYONIC HEART: A CASE STUDY IN BIO-INSPIRED ENGINEERING
M. Gharib (Pasadena, USA)
 
9:30 - 10:00 Coffee Break
10:00 - 11:30 Renal Session - Hemodiafiltration and Uremic Toxins Room E.06
Chair: D. Lumlertgul (Chiang Mai, Thailand), V. Teplan (Prague, Czech Republic)
10:00 SAFETY ASPECTS OF ONLINE HEMODIAFILTRATION (invited lecture)
V. Weber (Krems, Austria)
10:15 COMBINED APPLICATION OF HEMODIAFILTRATION AND PROFILER: SHORT AND MID-TERM CLINICAL RESULTS IN 16 PATIENTS 24
L. Colì, G. Donati, M. Ursino, G. Cianciolo, M. Piccari, G. Comai, V. Nastasi, D. Ricci, L. Stalteri, G. Ruggeri, S. Stefoni (Bologna, Italy)
10:30 IMPACT OF DIALYSIS DURATION ON THE REMOVAL OF UREMIC TOXINS 28
S. Eloot, W. Van Biesen, A. Dhondt, R. De Smet, P. Verdonck, R. Vanholder (Gent, Belgium )
10:45 QUANTIFICATION OF PHOSPHATE REMOVAL DURING LOW- AND HIGH-FLUX HAEMODIALYSIS (LFHD, HFHD) AND HAEMODIAFILTRATION (HDF) 40
F. Lopot, M. Turzová, F. Švára, V. Polakovič, B. Nejedlý (Prague, Czech Republic)
11:00 REMOVAL OF THE UREMIC RETENTION SOLUTE P-CRESOL USING FRACTIONATED PLASMA SEPARATION AND ADSORPTION  43
B.K. Meijers, V. Weber, B. Bammens, K. Verbeke, D. Falkenhagen, P. Evenepoel (Leuven, Belgium)
11:15 OXALIC ACID AS AN UREMIC TOXIN 46
M.Mydlík, K. Derzsiová (Košice, Slovak Republic)
11:30 - 12:30 Renal Session - Vascular Access and Anticoagulation
Chair: R. Ponikvar (Ljubljana, Slovenia),  M. Mydlik (Kosice, Slovakia)
11:30 CALCIUM-FREE VS. CALCIUM-CONTAINING DIALYSATE DURING REGIONAL CITRATE ANTICOAGULATION: A RANDOMIZED STUDY  19
J. Buturović-Ponikvar, S. Černe, J. Gubenšek, R. Ponikvar (Ljubljana, Slovenia)
11:45 HEMOFILTRATION SYSTEM  WITH PERFUSATE REPLACEMENT TROUGH THE HEMOFILTER MEMBRANE 20
D. Rodríguez-Martínez, J. Hurtado Roa, J.F. Del Cañizo (Madrid, Spain)
12:00 WARFARIN ANTICOAGULATION THERAPY FOR THE PREVENTION OF HEMODIALYSIS TUNNELED CUFFED CATHETERS THROMBOSIS 23
L.Colì, G. Donati, G. Cianciolo, C. Raimondi, M. Piccari, G. Comai, D. Ricci, F. Gozzetti, S. Stefoni (Bologna, Italy)
12:15 INCREASED EXTENT OF MICRO EMBOLI ARE PRESENT IN AV ACCESS AND CAROTIC ARTERY OF THE PATIENT AFTER START OF HD  30
U. Forsberg, P. Jonsson, C. Stegmayr, B. Stegmayr (Skelleftea, Sweden)
Saturday, September 8 2007 10:00 - 12:30 Heart Working Group - Cardiac Assist Room E.12
Chair: K. Affeld (Berlin, Germany), J.F. del Canizo (Madrid, Spain)
10:00 UPDATE ON CLINICAL ADULT AND PEDIATRIC VAD PROGRAMME 
B. Walpoth (Geneva, Switzerland)
10:15 RECENT DEVELOPMENTS IN MACHINE PERFUSION OF DONOR ORGANS
G. Rakhorst, A. van der Plaats, M.H. Maathuis and R.J. Ploeg (Groningen, The Netherlands)
10:30 INNOVATIONS AND IMPROVEMENTS OF THE DLR-VAD AND TET-SYSTEM
T. Schmid, W. Schiller, B. Vodermayer, D. Liepsch, A. Welz, G. Hirzinger (Wessling, Germany)
10:45 RECENT DEVELOPMENT IN HYBRID MODELLING OF CARDIOVASCULAR SYSTEM-POLISH/ITALIAN COOPERATION
M.Darowski, G.Ferrari, M.Kozarski, K.Gorczynska, C.De Lazzari, J.Palko, K.Zielinski, A.Tokarz. (Warsaw, Poland)
11:00 CARDIAC ASSIST AND TAH PROJECTS AT THE HIA: AN UPDATE 
U. Steinseifer (Aachen, Germany)
11:15 COLAPSABLE CARDIAC VALVES 
L. Goubergrits, K. Affeld (Berlin, Germany)
11:30 EXPERIENCE WITH ROTARY BLOOD PUMPS AT THE HEART CENTER NRW 
D. Roefe (Bad Oynhausen, Germany)
11:45 ONGOING PROJECTS IN VIENNA 
H. Schima, G. Wieselthaler (Vienna, Austria)
12:00 ONGOING PROJECTS IN MADRID
R. Perez-Caballero, D. Rodriguez-Martinez, M. Barranco, J.J. Gomez de Diego, J. F. del Canizo (Madrid, Spain)
12:15 PARTIAL SUPPORT FOR CHRONIC HEART FAILURE 
B. Meyns, F. Rega, I. Vantichelen, H. Bollen, V. Leunens, W. Kerckhoffs, O. Marseille.(Leuven, Belgium)
10:00 - 11:30 Biomaterials III Room E.11 
Chair: A. Werynski (Warsaw, Poland) , H. Mann (Aachen, Germany)
10:00 VALIDATION OF THE MATHEMATICAL MODELS OF THE HEMOGLOBIN GLYCATION WITH APPLICATION OF THE HUMAN ERYTHROCYTES CULTIVATION IN VITRO 83
P. Ladyzynski, J.M. Wojcicki, M. Bak, S. Sabalinska, J. Kawiak, P. Foltynski, J. Krzymien, W. Karnafel (Warsaw, Poland)
10:15 EXPRESSION OF MARKERS FOR METANEPHRIC DIFFERENTIATION INDUCED BY BUTYRIC AND HYALURONIC ESTERS 129
F. Bianchi, G. La Manna, S. Cantoni, C. Cavallini, I. Scarlata, M.L. Cappuccilli, E. Persici, M.P. Scolari, A. Perbellini, C. Ventura, S. Stefoni (Bologna, Italy)
10:30 EXTRACORPOREAL CIRCULATION (ECC) IN THE RAT MODEL USING A NEW MINIATURIZED HOLLOW FIBER OXYGENATOR 144
G.D. Cresce, D. Mugnai, M. Tessari, G. Faggian, A. Mazzucco, A. Kalangos, B.H. Walpoth (Geneva, Switzerland)
10:45 ACTIVE TRAINING STAND FOR IMPROVING THE NAVIGATION IN MANUAL OR ROBOTIC SUPPORTED MINIMAL INVASIVE SUGERY 149
P. Kostka, Z. Nawrat, Z. Malota (Zabrze, Poland)
11:00 NOVEL METHOD FOR THE REDUCTION AND/OR ELIMINATION OF BIOFILM INFECTIONS WITH IMPLANTED MEDICAL DEVICES 154
T. Mussivand, B. Jahangiri (Ottawa, Canada)
11:15 A SIGNAL TRANSMISSION FOR TWO INTRAOCULAR IMPLANTS 161
S. Klink, U. Gengenbach, G. Bretthauer, R. Guthoff (Karlsruhe, Germany)
11:30 - 12:30 Tissue Engineering II
Chair: B. Glasmacher (Hannover, Germany), M. Lysaght (Providence, USA)
11:30 PRODUCTION OF BONE SUBSTITUTES IN BIOREACTORS: MODELING AND CULTURE OF BONE MARROW STEM CELLS 172
B. Carpentier, J. Sohier, P. Layrolle, C. Legallais (Compiègne, France)
11:45 DEVELOPMENT OF NEW NERVE GUIDE TUBE FOR LONGER NERVE DEFECT 176
S. Ichihara, T. Nakamura, Y. Inada, S. Itoi, A. Nakada, K. Endo, T. Azuma, R. Nakai, S. Tsutsumi, K. Sakuraba, H. Kurosawa (Kyoto, Japan)
12:00 REGENERATIVE MEDICINE-ORIENTED VASCULAR GRAFTS: SALMON COLLAGEN TUBES 180
N. Nagai, Y. Nakayama, Y.M. Zhou, K. Takamizawa, K. Mori, S. Yunoki, M. Munekata (Hokkaido, Japan)
12:15 THE IMPACT OF HEART VALVE BIOPROSTHESIS PREPARATIONS PROCEDURE ON THE GLYCOSOAMINOGLYCANS STRUCTURE – GATEWAY TO IMPROVE THE DURABILITY OF THE PROSTHESIS 191
P. Wilczek, A. Barańska, M. Zembala (Zabrze, Poland)
12:30 - 13:00 Closing Ceremony Audi Max